With the holiday period, there are fewer updates to the site. Yet here is a digest of the key news and developments of the past week. You can access it at this link.
To receive further updates by email, please subscribe to the newsletter using the form in the right column of the website.
May 4, 2021 This article is about the “8th Day Therapy” concept developed by Dr Shankara Chetty from South Africa, who has treated… (147)
August 15, 2020 Australian radio host Luke Bona interviewed this August 12 Professor Thomas Borody, from the Centre for Digestive Diseases in Sydney,… (129)
September 18, 2021 This interview with Jessica Rose, PhD, covers the question of vaccine safety, as it can be evaluated from actual real… (80)
August 19, 2020 The Centre for Digestive Diseases issued today a press release titled “Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian… (75)
April 18, 2021 This is an audio presentation by Dr Henry Early about Vitamin D in relation to COVID-19. Dr Henry Ealy is… (70)
December 21, 2021 In this interview with internationally renowned Dr. Shankara Chetty from South Africa, we discuss the Omicron variant, which is taking… (66)
April 9, 2020 The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort… (63)
August 15, 2023 The event was organized at the Brussels facilities of the European Parliament. This was made possible by a handful of… (52)
August 30, 2023 Let’s summarize here the key points of our analysis, which shows that there is little rationale for any massive &… (48)
March 24, 2021 One of the most active analysts during this pandemic regarding the treatment of COVID-19 has been independent researcher Adam Gaertner.… (47)
Greetings and welcome. COVEXIT.com offers you independent global news and policy analysis regarding COVID-19, with emphasis on early treatments.
We are on Spotify and Apple Podcasts! Check our page listing all our podcasts.
We are on Twitter and also on GAB and Mewe.
Bonjour. Nous aurons prochainement du contenu nouveau via Substack. Vous êtes invité à vous y abonner!
